logo
  

DSM Closes Acquisition Of Andre Pectin's Stake - Quick Facts

Royal DSM N.V. (RDSMY.PK), a life and material science company, reported the completion of the acquisition of a 19% interest in Yantai Andre Pectin Co. Ltd., a China-based producer of texturing ingredients.

Previously, DSM had purchased a 10% stake in Andre Pectin from Hony Capital. DSM's total shareholding in Andre Pectin is currently 29%. The parties agreed that DSM has option rights to increase its stake in Andre Pectin to a majority stake at a later stage.

DSM said its investment in Andre Pectin, synergistically combined with the prior acquired China-based gellan gum assets, creates a China-based hydrocolloids growth platform, in line with its strategy for the Nutrition cluster, continued value growth.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Longmont Colorado -based Royal Crest Dairy is recalling 2% Chocolate Milk citing the potential to be contaminated with undeclared egg, a known allergen, the U.S. Food and Drug Administration said. The recall involves Farmer's 2% Reduced Fat Chocolate Milk Pints with the code date of AUG-22. ANI Pharmaceuticals, Inc. (ANIP) Monday announced a wider loss for the second quarter, despite a 52 percent surge in revenues. For the full year 2022, the company reiterated the adjusted earnings per share range, revenue guidance and raised Cortrophin revenue outlook. The company reported a quarterly... Shares of BioNTech SE were losing around 4 percent in the morning trading in Germany and around 5 percent in the pre-market activity on Nasdaq after the German Covid-19 vaccine maker reported sharp drop in profit and revenues for the second quarter. However, the company recorded strong growth in first-half results. Further, the company maintained BioNTech COVID-19 vaccine revenue guidance
RELATED NEWS
Follow RTT